Naomi Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 17-12-2024
- Paid Up Capital ₹ 5.48 M
as on 17-12-2024
- Company Age 20 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 8.20 M
as on 17-12-2024
- Revenue -32.58%
(FY 2022)
- Profit 1.99%
(FY 2022)
- Ebitda 321.58%
(FY 2022)
- Net Worth 1.92%
(FY 2022)
- Total Assets -7.27%
(FY 2022)
About Naomi Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.48 M.
The company has closed loans amounting to ₹8.20 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Suresh Santuka and Adyasha Santuka serve as directors at the Company.
- CIN/LLPIN
U24231OR2004PTC007477
- Company No.
007477
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jan 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Cuttack, Odisha, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Naomi Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Santuka  | Managing Director | 14-Aug-2012 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Adyasha Santuka | Director | 14-Aug-2012 | Current |
Financial Performance of Naomi Laboratories.
Naomi Laboratories Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 32.58% decrease. The company also saw a slight improvement in profitability, with a 1.99% increase in profit. The company's net worth moved up by a moderate rise of 1.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Naomi Laboratories?
In 2020, Naomi Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Santuka Homes Private LimitedActive 18 years 9 monthsSuresh Santuka and Adyasha Santuka are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Union Bank Of India Creation Date: 23 Mar 2013 | ₹8.00 M | Satisfied |
State Bank Of Hyderabad Creation Date: 05 Jan 2005 | ₹0.20 M | Satisfied |
How Many Employees Work at Naomi Laboratories?
Naomi Laboratories has a workforce of 17 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Naomi Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Naomi Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
